Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)

Poitiers University Hospital

Status: Completed

Conditions: Chemotherapy; 75 Years Old and More; Cancer

Treatments: Other: Self-questionnaire

Study type: Observational

Funder types: Other

Identifiers

NCT03261128

2017-A02188-45

Details and patient eligibility

About

Many cancers are diagnosed after 75 years. Treatment in chemotherapy begins without evidence of geriatric risk factors. A new tool for screening for geriatric fragilities is used, a self-administered questionnaire carried out by the patient before each chemotherapy cure. The objective is to secure the quality of patient care and to detect the appearance and / or aggravation of geriatric fragilities.

Full description

Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment:

• Number of D-FOGs filled in: comparison with the number of patients included in the study and the number of visits of each patient.
• Regularity of the D-FOG self-questionnaire by the patient: comparison with the number of visits of the patient for a chemotherapy cure (HDJ or HDS).
• Number of criteria entered by D-FOG: comparison with the total number of criteria to be filled in
• Criterion analysis of D-FOG

Enrollment: 50 patients

Sex: All

Ages: 75+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients aged 75 years and over
• Carriers of diagnosed cancer (excluding hematology)
• Whatever the location, uniqueness or multiple, duration of development and treatment status (adjuvant, neoadjuvant, locally advanced or metastatic)
• Seen in nursing consultant
• Beginning an oncological treatment
• Supported for oncology day hospital (HDJ) or weekly (HDS) chemotherapy
• Patient not opposed to participate in the study

Exclusion criteria

• Patients under 75 years of age
• Having not had an IDE ad consultation
• During oncological treatment
• Receiving Oral Therapy or hormone therapy alone
• Treated by radiotherapy alone or surgery alone
• Not attending a day or week oncology hospital
• Refusal to participate in research

Trial design

50 participants in 1 patient group

Group D-FOG

Description:

Filling of a self-questionnaire before each chemotherapy cure

Treatment:

Other: Self-questionnaire